Super excited about all the possible applications for these new protein diffusion generative models from
@namrata_anand2
! The contrast between diffusion for 3D structures vs images is fascinating. Great to see this progress on the structural side.
Excited to see
@namrata_anand2
work on generative AI models for protein design featured in the New York Times. Lots more to come from her new company, Diffuse Bio!
Our first result is Aristotle, a language model which advances the state of the art on MiniF2F, the standard dataset of formal mathematics problems statements. We are using Lean 4 for formal verification. 2/
We are excited to share three major updates today on our path to mathematical superintelligence 🦾
1. A new state-of-the-art of 90% on the MiniF2F benchmark. This beats our previously announced 83% from under a month ago.
Aristotle currently achieves an 83% success rate with computer algebra assistance, and a 63% proof rate at producing full Lean proofs. For more detail, please see 3/
We were able to achieve this state of the art performance predominantly with synthetic data, which gives us confidence that this approach can scale to true superintelligence. 4/
Following up on our diffusion generative models for proteins earlier this year: now we show their effectiveness for fitting density maps. So psyched about how fast this area is developing!
Excited to share results on fitting protein structures to density maps with diffusion models! Our setup uses priors from language models and simultaneously predicts the structure and fits the atomic model to densities, with zero pre- or post-processing. (1/3)
Super excited about all the possible applications for these new protein diffusion generative models from
@namrata_anand2
! The contrast between diffusion for 3D structures vs images is fascinating. Great to see this progress on the structural side.
Just released: open source package for fully AI-based sequence design and rotamer packing for arbitrary protein backbones, from
@namrata_anand2
. Potential use in designing Sars-CoV2 RBD binders etc. Check it out!